0000904454-24-000134.txt : 20240213
0000904454-24-000134.hdr.sgml : 20240213
20240213093652
ACCESSION NUMBER: 0000904454-24-000134
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
EFFECTIVENESS DATE: 20240213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Finepoint Capital LP
CENTRAL INDEX KEY: 0001608126
ORGANIZATION NAME:
IRS NUMBER: 462183973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16580
FILM NUMBER: 24622973
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 336-2200
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001608126
XXXXXXXX
12-31-2023
12-31-2023
false
Finepoint Capital LP
500 Boylston Street
24th Floor
Boston
MA
02116
13F HOLDINGS REPORT
028-16580
000170668
801-79330
N
Stacy L. Vezina
General Counsel
617-336-2212
Stacy L. Vezina
Boston
MA
02-13-2024
0
27
316969147
INFORMATION TABLE
2
infotable.xml
ACADIA PHARMACEUTICALS INC
COM
004225108
24097835
769653
SH
SOLE
769653
0
0
AMICUS THERAPEUTICS INC
COM
03152W109
21129265
1489025
SH
SOLE
1489025
0
0
ARVINAS INC
COM
04335A105
20773452
504700
SH
SOLE
504700
0
0
ASCENDIS PHARMA A/S
SPONSORED ADR
04351P101
20627083
163772
SH
SOLE
163772
0
0
CHURCHILL CAPITAL CORP VII
*W EXP 02/29/202
17144M110
71295
548000
SH
SOLE
548000
0
0
COMPASS DIGITAL ACQUISITION CORP
*W EXP 09/29/202
G2476C123
22259
459906
SH
SOLE
459906
0
0
CONCORD ACQUISITION CORP II
*W EXP 99/99/999
20607U116
53083
408333
SH
SOLE
408333
0
0
CYTOKINETICS INC
COM NEW
23282W605
36042049
431693
SH
SOLE
431693
0
0
CALIDI BIOTHERAPEUTICS INC
COM NEW
320703101
188750
125000
SH
SOLE
125000
0
0
CALIDI BIOTHERAPEUTICS INC
*W EXP 03/14/202
320703119
32760
655200
SH
SOLE
655200
0
0
GALAPAGOS NV
SPON ADR
36315X101
18644488
458659
SH
SOLE
458659
0
0
HOME PLATE ACQUISITION CORP
*W EXP 09/30/202
43734R111
20014212
331416
SH
SOLE
331416
0
0
LIBERTY BROADBAND CORP
COM SER C
530307305
14865631
184460
SH
SOLE
184460
0
0
MARBLEGATE ACQUISITION CORP
*W EXP 08/31/202
56608A113
22050
735000
SH
SOLE
735000
0
0
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
61559X104
62740
895000
SH
SOLE
895000
0
0
MORPHIC HOLDING INC
COM
61775R105
14349201
496856
SH
SOLE
496856
0
0
PROTHENA CORP PLC
SHS
G72800108
12693562
349300
SH
SOLE
349300
0
0
RELAY THERAPEUTICS INC
COM
75943R102
14509749
1317870
SH
SOLE
1317870
0
0
REVOLUTION MEDICINES INC
COM
76155X100
17698428
617100
SH
SOLE
617100
0
0
ROSS ACQUISITION CORP II
*W EXP 02/01/202
G7641C114
24621
439666
SH
SOLE
439666
0
0
SAREPTA THERAPEUTICS INC
COM
803607100
14016776
145357
SH
SOLE
145357
0
0
SOLID BIOSCIENCES INC
COM NEW
83422E204
5902081
961251
SH
SOLE
961251
0
0
SPIRIT AIRLINES INC
COM
848577102
27863000
1700000
SH
Call
SOLE
1700000
0
0
SPRINGWORKS THERAPEUTICS INC
COM
85205L107
20327872
556928
SH
SOLE
556928
0
0
SWIFTMERGE ACQUISITION CORP
*W EXP 12/13/202
G63836111
20090
490000
SH
SOLE
490000
0
0
TRAVERE THERAPEUTICS INC
COM
89422G107
12903536
1435321
SH
SOLE
1435321
0
0
YS BIOPHARMA CO LTD
*W EXP 03/15/202
G9845F117
13279
489999
SH
SOLE
489999
0
0